Investment
Features
FeesSafety
Academy
More
Pluang+

Compare General Motors Company (GM) vs Medtronic PLC (MDT) Price & Performance

General Motors CompanyTrade
Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

General Motors Company vs Medtronic PLC — how do they compare? General Motors Company trades at $89.2 (market cap $76.85B), while Medtronic PLC trades at $90.48 (market cap $114.45B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays the higher dividend (3.22%). Which is the better fit depends on your goals.

GMMDT
Market Cap
$76.85B$114.45B
Sector
Consumer CyclicalHealth
52-Week High
$90.30$105.35
52-Week Low
$54.16$73.75
Enterprise Value
$179.83B$133.19B
Dividend Yield
0.82%3.22%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

General Motors Company

No Aura AI signal available yet.

Medtronic PLC

Medtronic (MDT) trades at $87.16, up 1.44% today, with a bullish technical signal and consistent earnings beats. The company reported Q1 2026 EPS of $1.55, exceeding expectations, and maintains solid fundamentals with a 13.2% net income margin and $33.54B in revenue for 2025. Recent news highlights growth in cardiac ablation and the Hugo robotic platform, with management guiding for 11.75% organic revenue growth in Q1 2027.

The outlook is positive, supported by analyst consensus of a $98.75 price target and 60% buy ratings. Key opportunities include dividend stability and innovation in medical technology, while risks involve rising debt levels and competitive pressures. The stock's current valuation at a P/E of 23.37 offers moderate upside if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About General Motors Company

General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under four segments: GM North America, GM International, Cruise, and GM Financial. The United States now has four brands instead of eight under old GM. The company lost its U.S. market share leader crown in 2021 with share down 280 basis points to 14.6%, but we expect GM to reclaim the top spot in 2022 as 2021 suffered from the chip shortage. GM Financial became the company's captive finance arm in October 2010 via the purchase of AmeriCredit.

Read more on GM

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.

Read more on MDT